Appello Pharmaceuticals
Initial Transaction Details
Transaction Date
April 2018
Purpose of Financing
Venture
Stage of Company
Seed/Startup
Structure of Financing
Debt and Equity
Appello Pharmaceuticals, Inc. is a clinical-stage therapeutics company focused on identifying and developing innovative early-stage drug candidates for patients living with disorders of the nervous system. Based in Nashville, Tennessee, Appello has a strong collaborative relationship with Vanderbilt University’s Warren Center for Neuroscience Drug Discovery (WCNDD), where AP-472 was discovered.
Website